Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4770261

O=C(/C=C/c1cccc(F)c1)Nc1ccc2c(c1)CCN(C1CCC1)CC2.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.52
MAOB P27338 2/20 0.48
MMP1 P03956 3/20 0.47
MMP2 P08253 3/20 0.47
MMP9 P14780 3/20 0.47
DRD2 P14416 4/20 0.47
DRD3 P35462 4/20 0.47
CA12 O43570 3/20 0.45
CA9 Q16790 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
KDM4E B2RXH2 1/20 0.45
TRPV1 Q8NER1 1/20 0.44
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CCR2 P41597 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4770275 1.00 IMPDH2 (0.52) IMPDH2MAOBMMP1MMP2MMP9
SCHEMBL4765698 0.95 IMPDH2 (0.57) IMPDH2MAOBMMP1MMP2MMP9
SCHEMBL4765707 0.95 IMPDH2 (0.57) IMPDH2MAOBMMP1MMP2MMP9
Trifluoroacetic Acid SCHEMBL4774472 0.92 TRPV1 (0.50) MAOBMMP1MMP2MMP9NPC1
Trifluoroacetic Acid SCHEMBL4774480 0.92 TRPV1 (0.50) MAOBMMP1MMP2MMP9NPC1
Trifluoroacetic Acid SCHEMBL4767993 0.90 TRPV1 (0.51) MAOBMMP1MMP2MMP9DRD2
Trifluoroacetic Acid SCHEMBL4768005 0.90 TRPV1 (0.51) MAOBMMP1MMP2MMP9DRD2
Trifluoroacetic Acid SCHEMBL4768399 0.88 MAPT (0.49) IMPDH2MMP1MMP2MMP9DRD2
Trifluoroacetic Acid SCHEMBL4771953 0.88 MAPT (0.49) IMPDH2MMP1MMP2MMP9DRD2
SCHEMBL4773031 0.86 TRPV1 (0.53) MAOBMMP1MMP2MMP9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 IMPDH2 3166/4885MAOB 151/4885MMP1 4653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.